Elsevier

Journal of Diabetes and its Complications

Volume 19, Issue 6, November–December 2005, Pages 328-334
Journal of Diabetes and its Complications

Original article
A copper chelating agent suppresses carbonyl stress in diabetic rat lenses

https://doi.org/10.1016/j.jdiacomp.2005.08.002Get rights and content

Abstract

To clarify whether transition metals are involved in carbonyl stress in diabetic tissues, we observed the effects of a metal chelating agent, trientine (TE) hydrochloride on the levels of methylglyoxal (MG), 3-deoxyglucosone (3-DG), advanced glycation end products, 8-hydroxy-2′-deoxyguanosine (8-OHdG), and polyol pathway metabolites along with semicarbazide-sensitive amine oxidase (SSAO) enzyme activity in lenses from streptozotocin-induced diabetic rats. Lens MG and 3-DG levels were significantly higher in diabetic rats than nondiabetic controls, and TE significantly restored the increase of these compounds. Lens argpyrimidine was also increased in diabetic rats as compared with controls and was significantly reduced by TE. Lens SSAO activity and 8-OHdG were also significantly elevated in diabetic rats, and TE suppressed both of them, whereas TE showed no effect on the polyol pathway metabolites. The results indicate that transition metals play a significant role in the formation of MG and 3-DG via oxidative stress and SSAO activity.

Introduction

Carbonyl compounds such as methylglyoxal (MG) and 3-deoxyglucosone (3-DG) are recognized as most potent precursors of advanced glycation end products (AGEs), and the so-called carbonyl stress has recently attracted attention as the etiology of diabetic micro- and macroangiopathy (Baynes & Thorpe, 1999, McCance et al., 1993). Advanced glycation end products and dicarbonyl compounds are also known to contribute to the formation of cataract by aging (Ahmed et al., 1997, Shamsi et al., 1998) or by diabetes (Lyons et al., 1991, Sady et al., 2000). Of further interest, dicarbonyl compounds have been shown to cause direct damage to DNA as well (Murata-Kamiya & Kamiya, 2001, Shimoi et al., 2001), indicating a more potential role of the compounds in the development of diabetic complications.

Multiple synthetic routes of carbonyl compounds, from glucose and other carbohydrates or from lipids, require transition metals such as copper or iron. Transition metals are known to mediate the autoxidation of reducing sugars, the glycoxidation of Amadori products (Thornalley, Langborg, & Minhas, 1999), and the oxidation of lipids as well. These oxidative processes are involved in the formation of carbonyl compounds such as glyoxal (Fu et al., 1996). In addition, copper ion is essential for the activities of semicarbazide-sensitive amine oxidase (SSAO) that exerts as a synthetic enzyme for MG (Callingham, Crosbie, & Rous, 1995).

In accordance with these facts, previous studies showed that d-penicillamine, a chelating agent for copper, reduced AGEs in bovine lenses (Stevens, 1995) or human erythrocytes (Jakus, Hrnciarova, Carsky, Krahulec, & Rietbrock, 1999) incubated in high glucose medium. The results seem to indicate a tangible role of transition metals in the formation process of AGEs, yet it remains to be clarified if the reduction of AGEs is attributable to the suppression of carbonyl compounds by the chelating agent.

In present study, we observed effects of trientine (triethylenetetramine, TE), a copper chelating agent clinically used for treatment of Wilson's disease (Dahlman et al., 1995), on the levels of MG and 3-DG along with AGEs in lenses from streptozotocin-induced diabetic and nondiabetic rats. Lenses were chosen because the involvement of transition metals in lens AGE formation had been reported (Stevens, 1995). The activity of lens SSAO and the level of 8-hydroxy-2′-deoxyguanosine (8-OHdG) level, an indicator of oxidative stress (Fraga, Shigenaga, Park, Degan, & Ames, 1990), were also examined to elucidate the mechanisms by which TE may affect the carbonyl stress. The effects of TE on lens sorbitol and fructose were investigated as well, considering the possible involvement of the polyol pathway in the formation of 3-DG (Lal et al., 1995).

Section snippets

Animals

Six-week-old male Sprague–Dawley rats were purchased from Chubu Kagaku Shizai (Nagoya, Japan) and housed in an aseptic animal facility under control of room temperature (24°C), humidity (40–70%), and lighting (12-h cycle), with a free access to water and chow. Diabetes was induced by a single intravenous injection of 45 mg/kg of streptozotocin dissolved in 50 mmol/L citric acid buffer (pH 4.5). One week after injection, plasma glucose was determined and rats whose blood glucose levels were

Results

Plasma glucose levels were markedly elevated and body weights were decreased in diabetic rats as compared with nondiabetic controls (Table 1). Treatment with TE affected neither glucose levels nor body weights in each group.

As shown in Fig. 1, the levels of both MG and 3-DG were nearly three times higher in diabetic rats than nondiabetic controls (20.54±3.6 vs. 7.51±1.66 nmol/g tissue, P<.001, and 16.93±1.11 vs. 6.2±1.1 nmol/g tissue, P<.001, respectively). Treatment with TE resulted in the

Discussion

Among various dicarbonyl compounds, MG and 3-DG are putative precursors of AGEs seen in diabetic tissues. Methylglyoxal is the potential source of argpyrimidine (Shipanova, Glomb, & Nagaraj, 1997), carboxyethyllysine, and MG lysine dimer (MOLD) (Degenhardt, Thorpe, & Baynes, 1998), and 3-DG has been reported to yield pentosidine (Grandhee & Monnier 1991) and pyrraline (Hayase, Nagaraj, Miyata, Njoroge, & Monnier, 1989). Both MG and 3-DG have been shown to be increased in diabetic serum (

Acknowledgment

Trientine hydrochloride was kindly supplied by Tsumura Pharmaceutical. This study was partially supported by a diabetes research grant from the Ministry of Health and Welfare of Japan.

References (47)

  • H. Kato et al.

    Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats

    Biochimica et Biophysica Acta

    (1990)
  • S. Lal et al.

    Detection of fructose-3-phosphokinase activity in intact mammalian lenses by 31P NMR spectroscopy

    Journal of Biological Chemistry

    (1993)
  • S. Lal et al.

    Metabolism of fructose-3-phosphate in the diabetic rat lens

    Archives of Biochemistry and Biophysics

    (1995)
  • K.C. Mathys et al.

    Simicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methyglyoxal-AGE: Implications for vascular complications in diabetes

    Biochemical and Biophysical Research Communications

    (2002)
  • I. Miwa et al.

    Analysis of sorbitol, galactitol, and myo-inositol in lens and sciatic nerve by high-performance liquid chromatography

    Analytical Biochemistry

    (1988)
  • C. Sady et al.

    Maillard reactions by alpha-oxoaldehydes: Detection of glyoxal-modified proteins

    Biochimica et Biophysica Acta

    (2000)
  • K. Shimoi et al.

    Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells

    Mutation Research

    (2001)
  • I.N. Shipanova et al.

    Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct

    Archives of Biochemistry and Biophysics

    (1997)
  • H. Yamada et al.

    Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction

    Journal of Biological Chemistry

    (1994)
  • D.V. Zyzak et al.

    Formation of reactive intermediates from Amadori compounds under physiological conditions

    Archives of Biochemistry and Biophysics

    (1995)
  • M.U. Ahmed et al.

    N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

    Biochemical Journal

    (1997)
  • J.W. Baynes et al.

    Role of oxidative stress in diabetic complications: A new perspective on an old paradigm

    Diabetes

    (1999)
  • P.J. Beisswenger et al.

    Metformin reduces systemic methylglyoxal levels in type 2 diabetes

    Diabetes

    (1999)
  • Cited by (24)

    • Association between plasma concentration of copper and gestational diabetes mellitus

      2019, Clinical Nutrition
      Citation Excerpt :

      Second, Cu can increase the rate of advanced glycation end-products (AGEs) formation, which is associated with diabetes and its complications [37]. There is evidence that treatment of diabetic rats with Cu chelator could significantly reduce the levels of serum Cu as well as AGEs and AGE-precursors [38]. AGEs are deemed to produce the pathological Cu2+-binding sites in tissues, once AGEs-mediated Cu2+ binding is initiated, a feedforward process of Cu2+ catalysis becomes activated, thus further enhance the AGEs-modification and Cu2+ trapping potential [39].

    • The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementation

      2015, Medical Hypotheses
      Citation Excerpt :

      We therefore hypothesize that labile copper may mediate the risk that chelation therapy addresses. Over the last decade, a number of studies from several groups have demonstrated that treatment of diabetic rats or humans with the copper-selective chelating agent trientine – long used in the treatment of Wilson’s disease – can exert a range of favorable effects: improving endothelium-dependent vasodilation, alleviating diabetes-associated heart failure and hypertrophy, preventing renal fibrosis and albuminuria, and decreasing AGE formation in the lens [7–16]. Clinically, in diabetic patients with left ventricular hypertrophy at baseline, a one-year course of oral trientine (600 mg twice daily) was associated with a gradual reduction in left ventricular mass, whereas no change was observed in the patients receiving placebo [11].

    • Methylglyoxal induces cellular damage by increasing argpyrimidine accumulation and oxidative DNA damage in human lens epithelial cells

      2010, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Argpyrimidine is directly and rapidly formed from MGO. One month of diabetes may be enough to produce argpyrimidine in diabetic animal tissue [34]. Argpyrimidine is only one of the three known arginine modifications of MGO.

    View all citing articles on Scopus
    View full text